Bath & Body Works, Inc. (NYSE:BBWI – Get Free Report) announced a quarterly dividend on Friday, August 7th. Investors of record on Friday, August 21st will be given a dividend of 0.20 per share on Friday, September 4th. This represents a c) dividend on an annualized basis and a yield of 3.9%. The ex-dividend date is Friday, August 21st.
Bath & Body Works has raised its dividend payment by an average of 0.2%annually over the last three years. Bath & Body Works has a dividend payout ratio of 20.9% meaning its dividend is sufficiently covered by earnings. Equities research analysts expect Bath & Body Works to earn $2.90 per share next year, which means the company should continue to be able to cover its $0.80 annual dividend with an expected future payout ratio of 27.6%.
Bath & Body Works Price Performance
Bath & Body Works stock opened at $20.34 on Friday. Bath & Body Works has a 12-month low of $14.27 and a 12-month high of $32.32. The company has a market capitalization of $4.10 billion, a price-to-earnings ratio of 5.71, a price-to-earnings-growth ratio of 2.01 and a beta of 1.38. The firm’s fifty day moving average price is $20.30 and its 200 day moving average price is $20.29.
Analyst Ratings Changes
A number of research analysts recently commented on BBWI shares. UBS Group reduced their price target on Bath & Body Works from $22.00 to $19.00 and set a “neutral” rating for the company in a report on Wednesday, May 20th. The Goldman Sachs Group downgraded Bath & Body Works from a “neutral” rating to a “sell” rating and dropped their price objective for the stock from $23.00 to $19.00 in a report on Wednesday, July 8th. Piper Sandler began coverage on Bath & Body Works in a research report on Friday, May 15th. They issued a “neutral” rating and a $20.00 target price on the stock. Jefferies Financial Group increased their target price on Bath & Body Works from $22.00 to $23.00 and gave the company a “hold” rating in a research note on Tuesday, July 28th. Finally, Wells Fargo & Company raised their price target on shares of Bath & Body Works from $25.00 to $26.00 and gave the stock an “overweight” rating in a research report on Tuesday, June 23rd. Three investment analysts have rated the stock with a Buy rating, fourteen have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, Bath & Body Works presently has an average rating of “Hold” and an average target price of $21.93.
Check Out Our Latest Analysis on BBWI
Bath & Body Works Company Profile
Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.
Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.
See Also
- Five stocks we like better than Bath & Body Works
- Quantum Earnings Week: Winners and Losers Are Finally Emerging
- Axon’s Post-Earnings Pullback May Be More About Valuation Than Growth
- Uber Stock Lags in 2026, But Cash Flow and AV Bets Fuel Upside
- AppLovin Stock Hits 52-Week Low as Analysts Trim Targets, Stay Bullish
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.
